- Release Date: 07/08/24 09:08
- Summary: First Patient Treatment in the U.S. in the VISABL-AFL Trial
- Price Sensitive: Yes
- Download Document 231.49KB
- Forums
- ASX - By Stock
- Ann: First Patient Treatment in the U.S. in the VISABL-AFL Trial
IMR
imricor medical systems inc.
Add to My Watchlist
3.16%
!
$1.53

Ann: First Patient Treatment in the U.S. in the VISABL-AFL Trial
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.53 |
Change
-0.050(3.16%) |
Mkt cap ! $487.0M |
Open | High | Low | Value | Volume |
$1.58 | $1.58 | $1.51 | $473.4K | 309.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 497 | $1.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.56 | 2183 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 497 | 1.535 |
1 | 2500 | 1.530 |
3 | 3137 | 1.525 |
1 | 1837 | 1.520 |
2 | 1924 | 1.515 |
Price($) | Vol. | No. |
---|---|---|
1.555 | 2183 | 2 |
1.560 | 776 | 2 |
1.580 | 8200 | 1 |
1.650 | 6507 | 1 |
1.675 | 2000 | 1 |
Last trade - 12.08pm 17/06/2025 (20 minute delay) ? |
Featured News
IMR (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online